Universal-Beteiligungs- und Servicegesellschaft
VKTX icon

Universal-Beteiligungs- und Servicegesellschaft’s Viking Therapeutics VKTX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Buy
8,902
+1,305
+17% +$42.2K ﹤0.01% 1892
2026
Q1 		$247K Sell
7,597
-19,144
-72% -$615K ﹤0.01% 1926
2025
Q4 		$941K Buy
+26,741
New +$947K ﹤0.01% 1512
2025
Q3 		– Sell
-8,427
Closed -$223K – 2168
2025
Q2 		$223K Sell
8,427
-92
-1% -$2.42K ﹤0.01% 1910
2025
Q1 		$206K Buy
+8,519
New +$269K ﹤0.01% 1883

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's VKTX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Viking Therapeutics (VKTX) stake by 17% in Q2 2026, buying an estimated $42.2K and bringing the position to 8,902 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in VKTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $941K in Q4 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 8,902 shares of Viking Therapeutics worth $347K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 1,305 Viking Therapeutics shares in Q2 2026, an estimated $42.2K.
  • Viking Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1892 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Viking Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Viking Therapeutics position peaked at $941K in Q4 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.